Celularity is a cellular and regenerative medicine company that develops therapies and biomaterial products derived from placental tissue to treat age-related degenerative diseases and support wound care and surgical repair. The company generates revenue through three main channels: sales of commercial decellularized placental biomaterial products such as Biovance and Interfyl to hospitals and surgical centers; development and clinical advancement of cellular therapies including mesenchymal-like cells and engineered natural killer cells targeting aging processes; and biobanking services that collect, process, and preserve umbilical cord blood and placental cells for long-term storage, along with contract manufacturing services leveraging proprietary manufacturing processes and expertise.